molecular function |
| GO:0030246 | | carbohydrate binding | | Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates. |
| GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| GO:0016936 | | galactoside binding | | Interacting selectively and non-covalently with any glycoside in which the sugar group is galactose. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0043539 | | protein serine/threonine kinase activator activity | | Binds to and increases the activity of a protein serine/threonine kinase. |
| GO:0005102 | | receptor binding | | Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
biological process |
| GO:0098586 | | cellular response to virus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus. |
| GO:0006935 | | chemotaxis | | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| GO:0007565 | | female pregnancy | | The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
| GO:0007157 | | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | | The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell. |
| GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| GO:0045185 | | maintenance of protein location | | Any process in which a protein is maintained in a location and prevented from moving elsewhere. These include sequestration, stabilization to prevent transport elsewhere and the active retrieval of proteins that do move away. |
| GO:2000562 | | negative regulation of CD4-positive, alpha-beta T cell proliferation | | Any process that stops, prevents or reduces the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation. |
| GO:0010629 | | negative regulation of gene expression | | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| GO:0050728 | | negative regulation of inflammatory response | | Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
| GO:0032689 | | negative regulation of interferon-gamma production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
| GO:1902714 | | negative regulation of interferon-gamma secretion | | Any process that stops, prevents or reduces the frequency, rate or extent of interferon-gamma secretion. |
| GO:0032815 | | negative regulation of natural killer cell activation | | Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell activation. |
| GO:0043322 | | negative regulation of natural killer cell degranulation | | Any process that stops, prevents, or reduces the rate of natural killer cell degranulation. |
| GO:2000406 | | positive regulation of T cell migration | | Any process that activates or increases the frequency, rate or extent of T cell migration. |
| GO:0032722 | | positive regulation of chemokine production | | Any process that activates or increases the frequency, rate, or extent of chemokine production. |
| GO:0001819 | | positive regulation of cytokine production | | Any process that activates or increases the frequency, rate or extent of production of a cytokine. |
| GO:1900426 | | positive regulation of defense response to bacterium | | Any process that activates or increases the frequency, rate or extent of defense response to bacterium. |
| GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| GO:0045089 | | positive regulation of innate immune response | | Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection. |
| GO:0032732 | | positive regulation of interleukin-1 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-1 production. |
| GO:2001181 | | positive regulation of interleukin-10 secretion | | Any process that activates or increases the frequency, rate or extent of interleukin-10 secretion. |
| GO:2000778 | | positive regulation of interleukin-6 secretion | | Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion. |
| GO:0043032 | | positive regulation of macrophage activation | | Any process that stimulates, induces or increases the rate of macrophage activation. |
| GO:0051353 | | positive regulation of oxidoreductase activity | | Any process that activates or increases the frequency, rate or extent of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. |
| GO:0010862 | | positive regulation of pathway-restricted SMAD protein phosphorylation | | Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. |
| GO:0071902 | | positive regulation of protein serine/threonine kinase activity | | Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity. |
| GO:0045591 | | positive regulation of regulatory T cell differentiation | | Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells. |
| GO:2000679 | | positive regulation of transcription regulatory region DNA binding | | Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding. |
| GO:0032760 | | positive regulation of tumor necrosis factor production | | Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production. |
| GO:0010819 | | regulation of T cell chemotaxis | | Any process that modulates the rate, frequency or extent of T cell chemotaxis. T cell chemotaxis is the directed movement of a T cell in response to an external stimulus. |
| GO:0033081 | | regulation of T cell differentiation in thymus | | Any process that modulates the frequency, rate or extent of T cell differentiation in the thymus. |
| GO:2000316 | | regulation of T-helper 17 type immune response | | Any process that modulates the frequency, rate or extent of T-helper 17 type immune response. |
| GO:0032823 | | regulation of natural killer cell differentiation | | Any process that modulates the frequency, rate or extent of natural killer cell differentiation. |
| GO:0032496 | | response to lipopolysaccharide | | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
cellular component |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005622 | | intracellular | | The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |